<DOC>
	<DOCNO>NCT02474407</DOCNO>
	<brief_summary>This multi-center , open-label , crossover , pharmacokinetic , bioavailability study involve adolescent adult refractory ( drug-resistant ) epilepsy</brief_summary>
	<brief_title>A Study Determine Bioavailability , Safety Tolerability Diazepam Nasal Spray Versus Diazepam Rectal Gel ( Diastat® )</brief_title>
	<detailed_description>To determine bioavailability diazepam nasal spray versus diazepam rectal gel ( Diastat® ) condition use adolescent adult person epilepsy ( PWE ) meeting definition refractory epilepsy .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<mesh_term>Diazepam</mesh_term>
	<criteria>Diagnosis refractory epilepsy Body weight 26 111 kilogram ( kg ) inclusive Other inclusion criterion apply Male female subject surgically sterile female subject le 2 year postmenopausal , agree use highly effective birth control method study 3 month last dose investigational product Female subject pregnant , breastfeeding , plan become pregnant Presence history abnormality illness may affect absorption , distribution , metabolism elimination diazepam Other exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Seizures</keyword>
	<keyword>Epilepsy</keyword>
</DOC>